Kyntra Bio, Inc. (KYNB)
6.345
+0.38
(+6.46%)
USD |
NASDAQ |
Oct 09, 10:41
Kyntra Bio Price : 6.345 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 6.15 | 6.155 | 5.90 | 5.96 | 14960.00 |
| Oct 07, 2026 | 5.85 | 6.35 | 5.85 | 6.13 | 16833.00 |
| Oct 06, 2026 | 6.14 | 6.14 | 5.87 | 5.96 | 13678.00 |
| Oct 05, 2026 | 6.36 | 6.45 | 5.62 | 6.09 | 88804.00 |
| Oct 02, 2026 | 6.60 | 6.635 | 6.30 | 6.31 | 26079.00 |
| Oct 01, 2026 | 6.64 | 6.84 | 6.49 | 6.50 | 23998.00 |
| Sep 30, 2026 | 6.670 | 6.933 | 6.60 | 6.65 | 25472.00 |
| Sep 29, 2026 | 6.80 | 6.950 | 6.64 | 6.79 | 18046.00 |
| Sep 28, 2026 | 6.96 | 7.12 | 6.83 | 6.90 | 12227.00 |
| Sep 25, 2026 | 7.010 | 7.010 | 6.90 | 6.94 | 19745.00 |
| Sep 24, 2026 | 7.175 | 7.175 | 6.98 | 7.00 | 15537.00 |
| Sep 23, 2026 | 7.09 | 7.30 | 7.03 | 7.25 | 29102.00 |
| Sep 22, 2026 | 7.15 | 7.28 | 6.99 | 7.28 | 22495.00 |
| Sep 21, 2026 | 7.10 | 7.26 | 7.030 | 7.20 | 18565.00 |
| Sep 18, 2026 | 7.29 | 7.378 | 6.66 | 7.075 | 79876.00 |
| Sep 17, 2026 | 7.73 | 7.750 | 7.05 | 7.10 | 38618.00 |
| Sep 16, 2026 | 7.78 | 7.845 | 7.61 | 7.61 | 17730.00 |
| Sep 15, 2026 | 7.81 | 7.950 | 7.38 | 7.77 | 12094.00 |
| Sep 14, 2026 | 7.85 | 8.06 | 7.79 | 8.03 | 23777.00 |
| Sep 11, 2026 | 8.175 | 8.25 | 7.92 | 7.97 | 9683.00 |
| Sep 10, 2026 | 8.42 | 8.42 | 7.03 | 7.975 | 83887.00 |
| Sep 09, 2026 | 8.120 | 8.260 | 7.985 | 8.04 | 5902.00 |
| Sep 08, 2026 | 8.41 | 8.50 | 8.05 | 8.22 | 11049.00 |
| Sep 04, 2026 | 8.335 | 8.67 | 8.335 | 8.55 | 11906.00 |
| Sep 03, 2026 | 8.59 | 8.635 | 8.285 | 8.49 | 12430.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vericel Corp. | 40.93 |
| Nektar Therapeutics | 41.51 |
| Capricor Therapeutics, Inc. | 7.85 |
| ARS Pharmaceuticals, Inc. | 4.385 |
| ACADIA Pharmaceuticals, Inc. | 19.94 |
Price Related Metrics
| PE Ratio | 0.1964 |
| PS Ratio | 5.561 |
| Earnings Yield | 509.2% |
| Market Cap | 25.69M |
| Normalized PE Ratio | 0.1896 |